Purchases and Sales Made in Q2 2023 in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE) during Q2 2023. The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 11, 2023
Q2 2023
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-7K- 32.23% |
$31.7K - $58.8K
|
14.7K
$104K
|
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-12.3K- 46.88% |
$55.8K - $103K
|
14K
$98.4K
|
|
Aug 09, 2023
Q2 2023
|
Td Asset Management Inc
|
SELL
|
- |
-24.2K- 17.21% |
$110K - $204K
|
117K
$822K
|
|
Aug 14, 2023
Q2 2023
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.7M- 98.76% |
$7.68M - $14.2M
|
21.4K
$151K
|